Clinical Trial: A Clinical Study on Identifying High-Risk Postoperative Recurrence Population of Stage I EGFR-Mutated Lung Cancer Based on Multimodal Indicators and Early Intervention with Third-Generation TKIs (China)

China, Sept. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Clinical Study on Identifying High-Risk Postoperative Recurrence Population of Stage I EGFR-Mutated Lung Cancer Based on Multimodal Indicators and Early Intervention with Third-Generation TKIs'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133476

Registration Time: 2026/09/28

Type: Observational study

Primary Sponsor: Shanghai General Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336908

Published by HT Digital Content Services with permission from Health Daily Digest....